Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions was first published in 1977, and has been continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each annual provides clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing their expertise each year.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. v 6. Preface - p. xvii 7. Special Reviews in SEDA 38 - p. xix 8. Table of Essays, Annuals 1–37 - p. xxi 9. Abbreviations - p. xxiii 10. ADRs, ADEs and SEDs: A Bird's Eye View - p. xxiii 11. Chapter 1: Central Nervous System Stimulants and Drugs That Suppress Appetite - p. pgxli 12. Chapter 2: Antidepressant Drugs - p. 10 13. Chapter 3: Lithium - p. 19 14. Chapter 4: Hypnotics and Sedatives - p. 28 15. Chapter 5: Antipsychotic Drugs - p. 33 16. Chapter 6: Antiepileptics - p. 54 17. Chapter 7: Opioid Analgesics and Narcotic Antagonists - p. 70 18. Chapter 8: Anti-Inflammatory and Antipyretic Analgesics and Drugs Used in Gout - p. 76 19. Chapter 9: General Anaesthetics and Therapeutic Gases - p. 85 20. Chapter 10: Local Anesthetics - p. 95 21. Chapter 11: Neuromuscular Blocking Agents and Skeletal Muscle Relaxants - p. 104 22. Chapter 12: Drugs That Affect Autonomic Functions or the Extrapyramidal System - p. 113 23. Chapter 13: Dermatological Drugs, Topical Agents, and Cosmetics - p. 127 24. Chapter 14: Antihistamines (H1 Receptor Antagonists) - p. 141 25. Chapter 15: Drugs That Act on the Respiratory Tract - p. 151 26. Chapter 16: Positive Inotropic Drugs and Drugs Used in Dysrhythmias - p. 164 27. Chapter 17: Beta-Adrenoceptor Antagonists and Antianginal Drugs - p. 172 28. Chapter 18: Antihypertensives - p. 177 29. Chapter 19: Diuretics - p. 184 30. Chapter 20: Metals - p. 191 31. Chapter 21: Metal Antagonists - p. 204 32. Chapter 22: Antiseptic Drugs and Disinfectants - p. 210 33. Chapter 23: Beta-Lactams and Tetracyclines - p. 216 34. Chapter 24: Miscellaneous Antibacterial Drugs - p. 227 35. Chapter 25: Antifungal Drugs - p. 241 36. Chapter 26: Antiprotozoal Drugs - p. 253 37. Chapter 27: Antiviral Drugs - p. 259 38. Chapter 28: Drugs Used in Tuberculosis and Leprosy - p. 281 39. Chapter 29: Antihelminthic Drugs - p. 293 40. Chapter 30: Vaccines - p. 305 41. Chapter 31: Blood, Blood Components, Plasma, and Plasma Products - p. 334 42. Chapter 32: Vitamins, Amino Acids, and Drugs and Formulations Used in Nutrition - p. 353 43. Chapter 33: Drugs That Affect Blood Coagulation, Fibrinolysis and Hemostasis - p. 364 44. Chapter 34: Gastrointestinal Drugs - p. 377 45. Chapter 35: Drugs That Act on the Immune System: Cytokines and Monoclonal Antibodies - p. 393 46. Chapter 36: Drugs That Act on the Immune System: Immunosuppressive and Immunostimulatory Drugs - p. 405 47. Chapter 37: Corticotrophins, Corticosteroids, and Prostaglandins - p. 424 48. Chapter 38: Sex Hormones and Related Compounds, Including Hormonal Contraceptives - p. 431 49. Chapter 39: Thyroid hormones, Iodine and Iodides, and Antithyroid Drugs - p. 442 50. Chapter 40: Insulin Other Hypoglycemic Drugs - p. 452 51. Chapter 41: Miscellaneous Hormones - p. 462 52. Chapter 42: Drugs That Affect Lipid Metabolism - p. 467 53. Chapter 43: Cytostatic Agents—Tyrosine Kinase Inhibitors Utilized in the Treatment of Solid Malignancies - p. 477 54. Chapter 44: Radiological Contrast Agents and Radiopharmaceuticals - p. 491 55. Chapter 45: Drugs Used in Ocular Treatment - p. 501 56. Chapter 46: Safety of Complementary and Alternative Medicine (CAM) Treatments and Practices - p. 512 57. Chapter 47: Miscellaneous Drugs, Materials, Medical Devices and Techniques - p. 522 58. Reviewers List - p. 533 59. Index of Drugs - p. 535 60. Index of Drug-Drug Interactions - p. 545 61. Index of Adverse Effects and Adverse Reactions - p. 547
Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions was first published in 1977, and has been continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs. Each annual provides clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing their expertise each year.
1. Cover image - p. iv 2. Title page - p. iv 3. Table of Contents - p. iv 4. Copyright - p. iv 5. Contributors - p. v 6. Preface - p. xvii 7. Special Reviews in SEDA 38 - p. xix 8. Table of Essays, Annuals 1–37 - p. xxi 9. Abbreviations - p. xxiii 10. ADRs, ADEs and SEDs: A Bird's Eye View - p. xxiii 11. Chapter 1: Central Nervous System Stimulants and Drugs That Suppress Appetite - p. pgxli 12. Chapter 2: Antidepressant Drugs - p. 10 13. Chapter 3: Lithium - p. 19 14. Chapter 4: Hypnotics and Sedatives - p. 28 15. Chapter 5: Antipsychotic Drugs - p. 33 16. Chapter 6: Antiepileptics - p. 54 17. Chapter 7: Opioid Analgesics and Narcotic Antagonists - p. 70 18. Chapter 8: Anti-Inflammatory and Antipyretic Analgesics and Drugs Used in Gout - p. 76 19. Chapter 9: General Anaesthetics and Therapeutic Gases - p. 85 20. Chapter 10: Local Anesthetics - p. 95 21. Chapter 11: Neuromuscular Blocking Agents and Skeletal Muscle Relaxants - p. 104 22. Chapter 12: Drugs That Affect Autonomic Functions or the Extrapyramidal System - p. 113 23. Chapter 13: Dermatological Drugs, Topical Agents, and Cosmetics - p. 127 24. Chapter 14: Antihistamines (H1 Receptor Antagonists) - p. 141 25. Chapter 15: Drugs That Act on the Respiratory Tract - p. 151 26. Chapter 16: Positive Inotropic Drugs and Drugs Used in Dysrhythmias - p. 164 27. Chapter 17: Beta-Adrenoceptor Antagonists and Antianginal Drugs - p. 172 28. Chapter 18: Antihypertensives - p. 177 29. Chapter 19: Diuretics - p. 184 30. Chapter 20: Metals - p. 191 31. Chapter 21: Metal Antagonists - p. 204 32. Chapter 22: Antiseptic Drugs and Disinfectants - p. 210 33. Chapter 23: Beta-Lactams and Tetracyclines - p. 216 34. Chapter 24: Miscellaneous Antibacterial Drugs - p. 227 35. Chapter 25: Antifungal Drugs - p. 241 36. Chapter 26: Antiprotozoal Drugs - p. 253 37. Chapter 27: Antiviral Drugs - p. 259 38. Chapter 28: Drugs Used in Tuberculosis and Leprosy - p. 281 39. Chapter 29: Antihelminthic Drugs - p. 293 40. Chapter 30: Vaccines - p. 305 41. Chapter 31: Blood, Blood Components, Plasma, and Plasma Products - p. 334 42. Chapter 32: Vitamins, Amino Acids, and Drugs and Formulations Used in Nutrition - p. 353 43. Chapter 33: Drugs That Affect Blood Coagulation, Fibrinolysis and Hemostasis - p. 364 44. Chapter 34: Gastrointestinal Drugs - p. 377 45. Chapter 35: Drugs That Act on the Immune System: Cytokines and Monoclonal Antibodies - p. 393 46. Chapter 36: Drugs That Act on the Immune System: Immunosuppressive and Immunostimulatory Drugs - p. 405 47. Chapter 37: Corticotrophins, Corticosteroids, and Prostaglandins - p. 424 48. Chapter 38: Sex Hormones and Related Compounds, Including Hormonal Contraceptives - p. 431 49. Chapter 39: Thyroid hormones, Iodine and Iodides, and Antithyroid Drugs - p. 442 50. Chapter 40: Insulin Other Hypoglycemic Drugs - p. 452 51. Chapter 41: Miscellaneous Hormones - p. 462 52. Chapter 42: Drugs That Affect Lipid Metabolism - p. 467 53. Chapter 43: Cytostatic Agents—Tyrosine Kinase Inhibitors Utilized in the Treatment of Solid Malignancies - p. 477 54. Chapter 44: Radiological Contrast Agents and Radiopharmaceuticals - p. 491 55. Chapter 45: Drugs Used in Ocular Treatment - p. 501 56. Chapter 46: Safety of Complementary and Alternative Medicine (CAM) Treatments and Practices - p. 512 57. Chapter 47: Miscellaneous Drugs, Materials, Medical Devices and Techniques - p. 522 58. Reviewers List - p. 533 59. Index of Drugs - p. 535 60. Index of Drug-Drug Interactions - p. 545 61. Index of Adverse Effects and Adverse Reactions - p. 547
